No results matched your search
| Symbol | Exchange | Currency | ||
|---|---|---|---|---|
| PFE | NYSE | USD | Real-time | |
| PFE | Mexico | MXN | Delayed | |
| PFE | Stockholm | SEK | Delayed | |
| PFIZ | BSE | INR | Real-time | |
| PFIZ | NSE | INR | Real-time | |
| PFE | Hamburg | EUR | Delayed | |
| PFE | Berlin | EUR | Delayed | |
| PFE | Munich | EUR | Delayed | |
| PFE | Xetra | EUR | Delayed | |
| PFE | TradeGate | EUR | Delayed | |
| PFE | Frankfurt | EUR | Delayed | |
| PFE | Stuttgart | EUR | Delayed | |
| PFE | Buenos Aires | ARS | Delayed | |
| PFIZ34 | BM&FBovespa | BRL | Delayed | |
| PFE | Vienna | CHF | Delayed |
A drug that disappointed in 2018 will get an unexpected dance at the big ball.
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) announced that a higher dose of their NGF inhibitor, tanezumab, met the primary endpoint in a phase III study,...
Merck & Co., Inc, (NYSE:MRK) announced that a pivotal phase III study evaluating its PD-1 inhibitor, Keytruda for the second-line treatment of advanced hepatocellular...
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) will report fourth-quarter 2018 and full-year earnings results.The company has a disappointing track record as its key metrics missed...
| Type | 5 mins | 15 mins | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Neutral | Buy |
| Technical Indicators | Sell | Strong Sell | Strong Sell | BUY | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Neutral | Strong Buy |
Filter Table By:
| Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
|---|---|---|---|---|---|
| Emerging Patterns | |||||
| Evening Star | 15 | Current | |||
| Evening Star | 5H | Current | |||
| Completed Patterns | |||||
| Dark Cloud Cover | 1M | 2 | Dec 18 | ||
| Bullish Engulfing | 1W | 3 | Jan 27, 2019 | ||
| Three Inside Up | 15 | 3 | Feb 20, 2019 11:15AM | ||
| Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| NYSE | 42.12 | 0.00 | 0.00 | 5,398,198 | -1.11% | USD | 12:00:13 | ||
| Mexico | 820.65 | 760.01 | 830.00 | 0 | +0.00% | MXN | 19/02 | ||
| Stockholm | 393.0 | 0.0 | 0.0 | 2,274 | -1.26% | SEK | 11:29:00 | ||
| BSE | 2,895.00 | 0.00 | 0.00 | 8,250 | -0.43% | INR | 04:59:28 | ||
| NSE | 2,910.55 | 0.00 | 0.00 | 21,138 | -0.57% | INR | 05:28:22 | ||
| Hamburg | 37.540 | 37.100 | 37.130 | 0 | +0.13% | EUR | 02:00:00 | ||
| Berlin | 37.090 | 37.100 | 37.120 | 25 | -1.80% | EUR | 11:34:00 | ||
| Munich | 37.060 | 37.100 | 37.130 | 435 | -1.15% | EUR | 11:20:00 | ||
| Xetra | 37.080 | 37.050 | 37.290 | 1,800 | -1.33% | EUR | 11:35:00 | ||
| TradeGate | 37.040 | 37.050 | 37.060 | 3,838 | -1.85% | EUR | 11:48:00 | ||
| Frankfurt | 37.10 | 37.10 | 37.13 | 5,624 | -1.67% | EUR | 11:41:00 | ||
| Stuttgart | 37.470 | 36.970 | 37.270 | 0 | +0.13% | EUR | 02:05:00 | ||
| Buenos Aires | 840.00 | 0.00 | 0.00 | 0 | +0.00% | ARS | 19/02 | ||
| BM&FBovespa | 158.59 | 0.00 | 0.00 | 0 | +0.00% | BRL | 19/02 | ||
| Vienna | 37.620 | 0.000 | 0.000 | 0 | +0.21% | CHF | 19/02 |
| Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| Apple | 172.71 | 173.32 | 171.00 | +1.72 | +1.01% | 12.51M | 12:00:07 | ||
| Tesla | 302.21 | 306.30 | 301.46 | -3.47 | -1.14% | 3.60M | 12:00:06 | ||
| Netflix | 361.04 | 366.71 | 361.11 | -0.69 | -0.19% | 3.50M | 12:00:08 | ||
| Alphabet A | 1,130.63 | 1,130.60 | 1,125.00 | +3.90 | +0.35% | 320.87K | 11:59:48 | ||
| 162.86 | 163.72 | 161.89 | +0.53 | +0.33% | 4.18M | 12:00:13 | |||
| Amazon.com | 1,631.25 | 1,634.93 | 1,624.00 | +3.37 | +0.21% | 1.22M | 11:59:57 | ||
| CVS Health Corp | 64.92 | 65.13 | 63.30 | -4.95 | -7.08% | 29.05M | 12:00:10 | ||
| Arts-Way | 2.220 | 2.490 | 2.190 | -0.280 | -11.20% | 353.08K | 11:57:20 | ||
| Alibaba | 172.54 | 172.68 | 170.87 | +2.35 | +1.38% | 6.04M | 12:00:10 | ||
| NVIDIA | 159.88 | 161.26 | 157.40 | +3.19 | +2.04% | 6.98M | 12:00:08 |
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines, as well as consumer healthcare products. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines, as well as products for consumer healthcare. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.
Read More| Brokers | Regulation | Minimum Deposit | |
|---|---|---|---|
 |
U.S. Commodity Futures Trading Commission (United States) | $250 | Start Trading |
 |
U.S. Commodity Futures Trading Commission (United States) | Start Trading | |
 |
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) | $0 | Start Trading |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
